Drago Batinić

1.2k total citations
78 papers, 875 citations indexed

About

Drago Batinić is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Drago Batinić has authored 78 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 25 papers in Hematology and 15 papers in Oncology. Recurrent topics in Drago Batinić's work include Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Drago Batinić is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Drago Batinić collaborates with scholars based in Croatia, United States and Germany. Drago Batinić's co-authors include Frank A. Robey, Dora Višnjić, Hrvoje Banfíƈ, Boris Labar, Branka Užarević, Matko Marušić, Hrvoje Lalić, Stefano Volinia, Damir Nemet and Marija Jelušić and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Drago Batinić

72 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drago Batinić Croatia 16 352 258 188 127 110 78 875
Jose L. Lepe‐Zuniga United States 13 210 0.6× 152 0.6× 340 1.8× 182 1.4× 60 0.5× 20 928
Ian T. Magrath United States 7 220 0.6× 291 1.1× 584 3.1× 269 2.1× 186 1.7× 9 1.2k
Frances M. Gibson United Kingdom 20 335 1.0× 755 2.9× 383 2.0× 209 1.6× 59 0.5× 56 1.4k
William E. Hobbs United States 14 182 0.5× 274 1.1× 282 1.5× 81 0.6× 37 0.3× 29 895
Éric Piver France 19 379 1.1× 99 0.4× 314 1.7× 95 0.7× 28 0.3× 51 1.5k
Myew–Ling Toh France 18 213 0.6× 174 0.7× 541 2.9× 185 1.5× 28 0.3× 23 1.0k
Guglielmo Rosignoli United Kingdom 14 418 1.2× 103 0.4× 430 2.3× 106 0.8× 47 0.4× 21 886
Patrick T. Bruck Germany 20 194 0.6× 533 2.1× 195 1.0× 290 2.3× 46 0.4× 35 1.3k
Doroti Pirulli Italy 18 288 0.8× 36 0.1× 241 1.3× 105 0.8× 41 0.4× 33 821
Morten Nørgaard Andersen Denmark 18 335 1.0× 100 0.4× 460 2.4× 297 2.3× 37 0.3× 38 1.0k

Countries citing papers authored by Drago Batinić

Since Specialization
Citations

This map shows the geographic impact of Drago Batinić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drago Batinić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drago Batinić more than expected).

Fields of papers citing papers by Drago Batinić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drago Batinić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drago Batinić. The network helps show where Drago Batinić may publish in the future.

Co-authorship network of co-authors of Drago Batinić

This figure shows the co-authorship network connecting the top 25 collaborators of Drago Batinić. A scholar is included among the top collaborators of Drago Batinić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drago Batinić. Drago Batinić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dembitz, Vilma, Hrvoje Lalić, Ivan Kodvanj, et al.. (2020). 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts. BMC Cancer. 20(1). 1090–1090. 6 indexed citations
2.
Barun, Barbara, Tereza Gabelić, Ivan Adamec, et al.. (2020). Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness. Multiple Sclerosis and Related Disorders. 48. 102704–102704. 31 indexed citations
3.
Batinić, Josip, Zinaida Perić, James I. Last, et al.. (2015). Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients. Croatian Medical Journal. 56(3). 263–271. 10 indexed citations
4.
Katić, Jelena, Eleni Fthenou, Manolis Kogevinas, et al.. (2013). Increased frequency of micronuclei in mononucleated lymphocytes and cytome analysis in healthy newborns as an early warning biomarkers of possible future health risks. Reproductive Toxicology. 42. 110–115. 10 indexed citations
5.
6.
Šoljić, Violeta, et al.. (2012). ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia. Leukemia & lymphoma. 54(6). 1171–1176. 6 indexed citations
7.
Gajski, Goran, Ana‐Marija Domijan, Ivančica Delaš, et al.. (2012). Carboplatin resistant human laryngeal carcinoma cells are cross resistant to curcumin due to reduced curcumin accumulation. Toxicology in Vitro. 27(2). 523–532. 15 indexed citations
8.
Batinić, Drago, et al.. (2008). Biological features and outcome of biphenotypic acute leukemia. Hematology/Oncology and Stem Cell Therapy. 1(4). 225–230. 7 indexed citations
9.
10.
Batinić, Drago, et al.. (2006). Protočna citometrija u hematologiji. 50. 176–182.
11.
Karlović, Dalibor, et al.. (2006). Lithium increases expression of p21WAF/Cip1 and survivin in human glioblastoma cells. Cell Biology and Toxicology. 23(2). 83–90. 14 indexed citations
12.
Nemet, Damir, Ivo Radman, Igor Aurer, et al.. (2003). High-Dose Ifosfamide and Mitoxantrone (HDIM) as Cytoreductive and Mobilisation Protocol for Relapsed and Refractory Lymphoma. Blood. 1 indexed citations
13.
Potočki, Kristina, et al.. (2003). Progressive form of pulmonary Langerhans’ cell histiocytosis in a female adult non‐smoker. Respirology. 8(4). 525–528. 1 indexed citations
14.
Sučić, Mirna, Renata Zadro, Boris Labar, et al.. (2002). Acute Promyelocytic Leukemia M3: Cytomorphologic, Immunophenotypic, Cytogenetic, and Molecular Variants. Journal of Hematotherapy & Stem Cell Research. 11(6). 941–950. 23 indexed citations
15.
Užarević, Branka, et al.. (2002). Immunological detection of minimal residual disease in acute leukaemia. Biochemia Medica. 12. 97–104.
16.
Višnjić, Dora, et al.. (2002). Antiproliferative effect of phosphatidylinositol 3-kinase inhibitor LY294002 on HL-60 and K562 leukemia cell lines. Periodicum Biologorum. 104(4). 405–411. 2 indexed citations
17.
Sučić, Mirna, Branka Užarević, Renata Zadro, et al.. (1999). Double Immunoenzymatic APAAP Staining for the Detection of Leukemia-Associated Immunophenotypes. Journal of Hematotherapy & Stem Cell Research. 8(6). 635–643. 3 indexed citations
18.
Poljak, Ljiljana, Srđan Verstovšek, Nikola Knežević, et al.. (1992). Cyclosporine A differetly affects the function of the two main T cell subsets. Croatian Medical Journal. 33. 102–106. 1 indexed citations
19.
Užarević, Branka, Drago Batinić, Mladen Petrovečki, & Matko Marušić. (1992). Leukocyte membrane markers on cell populations defined by six flow cytometric bitmaps. Journal of Clinical Laboratory Analysis. 6(1). 17–23. 6 indexed citations
20.
Robey, Frank A., et al.. (1992). Peptomers as Vaccine Candidates. Advances in experimental medicine and biology. 327. 209–215. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jose L. Lepe‐Zuniga Breakdown of academic impact, for papers by Ian T. Magrath Breakdown of academic impact, for papers by Frances M. Gibson Breakdown of academic impact, for papers by William E. Hobbs Breakdown of academic impact, for papers by Éric Piver Breakdown of academic impact, for papers by Myew–Ling Toh Breakdown of academic impact, for papers by Guglielmo Rosignoli Breakdown of academic impact, for papers by Patrick T. Bruck Breakdown of academic impact, for papers by Doroti Pirulli Breakdown of academic impact, for papers by Morten Nørgaard Andersen
Rankless by CCL
2026